查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1493532

血型分型市場 - 全球產業規模、佔有率、趨勢、機會和預測，按產品、技術、測試類型、最終用戶、地區和競爭細分，2019-2029F

Blood Group Typing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Technique, By Test Type, By End User, By Region, and By Competition, 2019-2029F
出版日期: | 出版商: TechSci Research | 英文 184 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2023 年，全球血型分型市場估值為20.1 億美元，到2029 年，預測期內將以8.76% 的複合年成長率實現令人印象深刻的成長。是一種用於識別血型的實驗室方法。主要血型系統包括ABO系統和Rh系統，但還有許多其他次要血型系統也可以透過血型來辨識。匹配供血者與受血者的血型對於防止輸血期間的不良反應至關重要。不相容的輸血可能導致溶血反應，危及生命。器官捐贈者和接受者之間的血型相容性對於防止器官排斥並確保器官移植手術的成功是必要的。孕婦的血型分型對於識別因母親和胎兒之間的血型不相容而導致新生兒溶血病 (HDN) 的任何潛在風險至關重要。

市場概況
預測期 2025-2029
2023 年市場規模 20.1億美元
2029 年市場規模 33.3億美元
2024-2029 年複合年成長率 8.76%
成長最快的細分市場 基於測定的技術
最大的市場 北美洲

全世界慢性病、外科手術和創傷病例的盛行率不斷上升，導致對輸血的需求不斷增加。準確的血型分型對於確保捐贈者和受血者血液之間的兼容性至關重要，從而推動了對血型產品和服務的需求。分子診斷、自動化和即時檢測等血型方法的技術進步提高了血型測定程序的準確性、速度和效率。這些進步透過提高血型服務的可靠性和可近性來推動市場成長。向個人化醫療和客製化治療方法的轉變強調了精確血型分型在輸血和移植醫學中的重要性。血型分析使醫療保健提供者能夠根據接受者的特定基因圖譜將血液製品和器官與接受者進行匹配，從而改善治療結果並降低不良反應的風險。血庫基礎設施的擴張，特別是在新興經濟體，支持了全球血型定型市場的成長。增加對醫療基礎設施、捐血活動和血液處理設施建設的投資有助於在不同的醫療環境中提供血型服務。全球不斷增加的醫療保健支出，加上政府改善醫療保健可近性和品質的舉措，透過擴大先進血型技術和服務的採用來推動市場成長。醫療保健提供者分配資源來提升血型檢測能力，以滿足對輸血和移植服務不斷成長的需求。

主要市場促進因素

血型鑑定技術的進步

輸血需求增加

血庫基礎設施的擴建

主要市場挑戰

血型系統的複雜性

需要高精度和高精度

主要市場趨勢

增加捐血活動

細分市場洞察

技術見解

測試類型見解

區域洞察

目錄

第 1 章：產品概述

第 2 章：研究方法

第 3 章：執行摘要

第 4 章：客戶之聲

第 5 章：全球血型分型市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品（消耗品、儀器、服務）
    • 按技術（基於 PCR 和微陣列技術、基於測定的技術、大規模平行定序、其他）
    • 依檢測類型（抗體篩檢、HLA 分型、ABO 血液檢測、交叉配血檢測、抗原分型）
    • 按最終使用者（醫院、臨床實驗室、血庫、其他最終使用者）
    • 按地區
    • 按公司分類 (2023)
  • 市場地圖

第 6 章：北美血型分型市場前景

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品分類
    • 依技術
    • 按測試類型
    • 按最終用戶
    • 按國家/地區
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第 7 章：歐洲血型分型市場前景

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品分類
    • 依技術
    • 按測試類型
    • 按最終用戶
    • 按國家/地區
  • 歐洲：國家分析
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙

第 8 章：亞太地區血型分型市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品分類
    • 依技術
    • 按測試類型
    • 按最終用戶
    • 按國家/地區
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第 9 章：南美洲血型分型市場前景

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品分類
    • 依技術
    • 按測試類型
    • 按最終用戶
    • 按國家/地區
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲血型分型市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品分類
    • 依技術
    • 按測試類型
    • 按最終用戶
    • 按國家/地區
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 促進要素
  • 挑戰

第 12 章：市場趨勢與發展

  • 併購（如有）
  • 產品發布（如有）
  • 最近的發展

第 13 章：波特的五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 客戶的力量
  • 替代產品的威脅

第14章：競爭格局

  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Illumina, inc.
  • Immucor, inc.
  • CareDx Inc.
  • Mesa Laboratories, Inc.
  • Bio-Rad Laboratories, Inc.
  • Merck KgaA
  • AliveDx Suisse SA
  • QuidelOrtho Corporation

第 15 章：策略建議

第16章調查會社について,免責事項

簡介目錄
Product Code: 23728

Global Blood Group Typing Market was valued at USD 2.01 billion in 2023 and will see an impressive growth in the forecast period at a CAGR of 8.76% through 2029. Blood group typing, also known as blood typing, is a laboratory method used to identify the specific blood group antigens present on the surface of red blood cells (RBCs) and the corresponding antibodies present in the plasma. The primary blood group systems include the ABO system and the Rh system, but there are many other minor blood group systems that can also be identified through blood typing. Matching the blood type of the donor with that of the recipient is critical to prevent adverse reactions during blood transfusions. Incompatible blood transfusions can lead to hemolytic reactions, which can be life-threatening. Blood group compatibility between organ donors and recipients is necessary to prevent organ rejection and ensure the success of organ transplantation procedures. Blood group typing of pregnant women is essential to identify any potential risks of hemolytic disease of the newborn (HDN) due to blood group incompatibilities between the mother and fetus.

Market Overview
Forecast Period2025-2029
Market Size 2023USD 2.01 Billion
Market Size 2029USD 3.33 Billion
CAGR 2024-20298.76%
Fastest Growing SegmentAssay-Based Techniques
Largest MarketNorth America

The rising prevalence of chronic diseases, surgical procedures, and trauma cases worldwide has led to a growing demand for blood transfusions. Accurate blood group typing is essential to ensure compatibility between donor and recipient blood, driving the need for blood typing products and services. Technological advancements in blood typing methods, such as molecular diagnostics, automation, and point-of-care testing, have improved the accuracy, speed, and efficiency of blood typing procedures. These advancements drive market growth by enhancing the reliability and accessibility of blood typing services. The shift towards personalized medicine and tailored treatment approaches emphasizes the importance of precise blood group typing in transfusion and transplantation medicine. Blood typing enables healthcare providers to match blood products and organs with recipients based on their specific genetic profiles, improving treatment outcomes and reducing the risk of adverse reactions. The expansion of blood banking infrastructure, especially in emerging economies, supports the growth of the global blood group typing market. Increasing investments in healthcare infrastructure, blood donation campaigns, and the establishment of blood processing facilities contribute to the availability of blood typing services in diverse healthcare settings. The increasing healthcare expenditure globally, coupled with government initiatives to improve healthcare accessibility and quality, drives market growth by expanding the adoption of advanced blood typing technologies and services. Healthcare providers allocate resources towards upgrading blood typing capabilities to meet the growing demand for transfusion and transplantation services.

Key Market Drivers

Advancements in Blood Typing Technologies

Molecular typing methods, such as polymerase chain reaction (PCR) and nucleic acid sequencing, enable the detection and identification of specific genetic markers associated with different blood groups. These methods offer high levels of accuracy and precision, particularly in identifying rare or complex blood group antigens. Automation and robotics have revolutionized blood typing laboratories by streamlining workflows, reducing human error, and increasing throughput. Automated platforms perform blood typing assays, sample handling, and data analysis with minimal manual intervention, improving efficiency and standardization in blood typing procedures.

Point-of-care testing devices allow for rapid blood typing and compatibility testing at the bedside or in remote settings, such as emergency departments, ambulances, and field hospitals. POCT devices provide real-time results, enabling prompt decision-making for blood transfusions and emergency medical interventions. Multiplex assays simultaneously detect multiple blood group antigens and antibodies in a single test, offering comprehensive blood typing profiles in a shorter time frame. These assays enhance efficiency, conserve sample volume, and facilitate the identification of complex blood group phenotypes. High-throughput screening platforms enable the simultaneous analysis of large numbers of blood samples, making them well-suited for blood typing in blood banks, donor centers, and large-scale screening programs. These platforms leverage advanced technologies, such as microarrays and flow cytometry, to expedite blood typing processes and enhance laboratory productivity.

Next-generation sequencing techniques allow for the comprehensive analysis of blood group genes and genetic variations associated with blood group antigens. NGS platforms offer high resolution and sensitivity, enabling the detection of novel blood group alleles and facilitating precise blood typing in diverse patient populations. Bioinformatics tools and data analysis algorithms play a crucial role in interpreting complex blood typing data, identifying genetic variants, and predicting blood group phenotypes. These tools enable researchers and healthcare providers to analyze large datasets, uncover genotype-phenotype associations, and improve the accuracy of blood typing results. Customized testing panels allow laboratories to tailor blood typing assays based on specific clinical requirements, patient populations, and testing objectives. Customization options include selecting target antigens, optimizing assay parameters, and integrating complementary testing methodologies to meet diverse clinical needs. This factor will help in the development of the Global Blood Group Typing Market.

Increasing Demand for Blood Transfusions

Blood group typing is essential to ensure compatibility between donor blood and recipient blood during transfusions. Knowing the blood type of both the donor and recipient helps prevent adverse reactions, such as transfusion reactions or hemolytic reactions, which can be life-threatening. Transfusion reactions can occur when incompatible blood types are transfused into recipients. Blood group typing helps identify the presence of antigens on red blood cells and antibodies in plasma, allowing healthcare providers to select compatible blood products and minimize the risk of transfusion reactions. Accurate blood group typing facilitates precise matching of donor blood to recipient blood, ensuring that the transfused blood is compatible and safe for the patient. This is particularly crucial for patients who require frequent or ongoing transfusions due to medical conditions such as anemia, cancer, or surgical procedures.

Blood group typing contributes to patient safety by reducing the likelihood of transfusion-related complications and adverse events. By accurately identifying blood types and matching blood products, healthcare providers can minimize the risks associated with transfusions and improve patient outcomes. The increasing demand for blood transfusions reflects the growing healthcare needs of populations worldwide. Factors such as aging populations, advances in medical treatments, and rising incidences of trauma and chronic diseases contribute to the rising demand for blood products and blood typing services. Blood transfusions are often required in emergency medical situations, such as trauma cases, surgical emergencies, and obstetric complications. Rapid and accurate blood group typing is essential in these scenarios to facilitate timely transfusions and save lives. Public health initiatives aimed at increasing blood donation rates and ensuring the availability of safe blood products further drive the demand for blood group typing services. Blood typing is an integral part of blood screening protocols to maintain the safety and quality of the blood supply. This factor will pace up the demand of the Global Blood Group Typing Market

Expansion of Blood Banking Infrastructure

With the expansion of blood banking infrastructure, including the establishment of new blood banks and donation centers, there is a greater volume of blood collected and processed for transfusion purposes. Blood banks require comprehensive blood group typing services to ensure the compatibility of donated blood with potential recipients. The expansion of blood banking infrastructure often leads to increased diversity in the donor pool, with donors from different ethnic, racial, and geographic backgrounds. As a result, there is a greater need for comprehensive blood group typing services to accurately characterize the diverse range of blood types present in the donor population. Blood banks play a crucial role in emergency preparedness and response efforts during natural disasters, mass casualty incidents, and other emergencies. Rapid and accurate blood group typing services are essential for quickly assessing the available blood inventory, identifying compatible blood products, and addressing the transfusion needs of patients in emergency situations. Blood banking infrastructure expansion involves the implementation of sophisticated blood supply management systems to track blood inventory, monitor expiration dates, and optimize blood distribution. Blood group typing services are integral to these management systems, providing essential data for inventory management and ensuring the availability of compatible blood products when needed.

Blood banks are subject to stringent regulatory requirements and quality assurance standards to maintain the safety, efficacy, and integrity of the blood supply. Blood group typing services play a critical role in ensuring regulatory compliance by accurately characterizing blood types, screening for infectious diseases, and performing compatibility testing in accordance with regulatory guidelines. The expansion of blood banking infrastructure enables the production and distribution of specialized blood products, such as frozen plasma, platelets, and cryoprecipitate, for specific clinical indications and patient populations. Blood group typing services are essential for characterizing these specialized blood products and ensuring their compatibility with recipient blood. Advances in transfusion medicine, including the development of novel blood products, transfusion protocols, and therapeutic approaches, drive the demand for blood group typing services. Blood group typing facilitates personalized transfusion strategies tailored to individual patient needs, improving transfusion outcomes and patient safety. This factor will accelerate the demand of the Global Blood Group Typing Market

Key Market Challenges

Complexity of Blood Group Systems

Blood group systems encompass a wide range of antigens present on the surface of red blood cells. These antigens can vary significantly in terms of their molecular structure, distribution in different populations, and clinical significance. The diversity of blood group antigens complicates blood typing procedures and requires comprehensive testing methodologies to accurately characterize blood types. Some blood group antigens are rare or uncommon, making them challenging to detect using traditional serological methods. Identifying and typing rare antigens require specialized reagents, advanced testing techniques, and expertise in immunohematology, increasing the complexity and cost of blood typing procedures. Blood group antigens may exhibit variability in expression levels, genetic polymorphisms, and antigenic determinants among individuals and populations. This variability can lead to discrepancies in blood typing results, false-negative or false-positive reactions, and challenges in interpreting blood group phenotypes accurately.

Need for High Accuracy and Precision

Ensuring the accuracy of blood group typing is critical for patient safety during blood transfusions. Inaccurate blood typing results can lead to transfusion reactions, hemolytic episodes, and other adverse events that jeopardize patient health and well-being. Mismatched blood transfusions due to inaccurate blood typing can result in severe transfusion reactions, including hemolytic reactions, allergic reactions, and acute immune-mediated complications. The potential consequences of transfusion reactions underscore the importance of achieving high accuracy and precision in blood typing procedures. Blood group typing involves the characterization of complex blood group systems, including the ABO system, Rh system, and numerous minor blood group antigens. The diverse range of antigens and their genetic variants increase the complexity of blood typing assays and require meticulous attention to detail to ensure accuracy and precision. Serological blood typing assays rely on the interpretation of antigen-antibody reactions, which can be subject to interpretation variability and subjective judgment. Achieving consistent and reproducible results across different laboratory settings requires standardized protocols, quality control measures, and ongoing training for laboratory personnel.

Key Market Trends

Increasing Blood Donation Initiatives

Blood donation initiatives aim to increase the number of voluntary blood donors, thereby expanding the pool of available blood products for transfusion. A larger donor pool enhances the availability of diverse blood types, facilitating better matching and compatibility with recipients. Encouraging blood donation from a diverse range of donors helps ensure the availability of blood products with various blood types and antigen profiles. This diversity is crucial for meeting the transfusion needs of patients with specific blood group requirements, including those with rare or uncommon blood types. Blood donation initiatives contribute to maintaining an adequate and stable blood supply, which is essential for meeting the demands of healthcare facilities and responding to emergency situations, such as natural disasters, mass casualty incidents, and pandemics. Increasing blood donation rates supports transfusion safety by reducing the reliance on directed or replacement blood donations, which may carry a higher risk of transfusion-transmitted infections and other adverse events. Voluntary blood donation programs promote a culture of altruism, community engagement, and public health awareness regarding the importance of blood donation and transfusion safety.

Segmental Insights

Technique Insights

The Assay-Based Techniques segment is projected to experience rapid growth in the Global Blood Group Typing Market during the forecast period. Assay-based techniques, such as polymerase chain reaction (PCR), microarray analysis, and flow cytometry, offer high levels of accuracy and precision in blood group typing. These techniques allow for the detection of specific genetic markers and antigen profiles associated with different blood groups, enabling more reliable and consistent typing results. Assay-based techniques are often automated and capable of high throughput, allowing for the rapid processing of large numbers of samples in a relatively short period. This scalability and efficiency make assay-based methods well-suited for blood typing in blood banks, hospitals, and clinical laboratories with high testing volumes. Assay-based techniques enable the identification and typing of a broader range of blood group antigens beyond the ABO and Rh systems. This expanded antigen typing capability is particularly valuable in situations where comprehensive blood group matching is required for blood transfusions, organ transplantation, and prenatal testing.

Test Type Insights

The Antibody Screening segment is projected to experience rapid growth in the Global Blood Group Typing Market during the forecast period. With a growing number of blood transfusions being performed worldwide, there is a heightened emphasis on ensuring the safety and compatibility of blood products. Antibody screening plays a critical role in identifying antibodies in patient blood samples, which helps prevent transfusion reactions and ensures patient safety during blood transfusions. The prevalence of chronic diseases such as cancer, autoimmune disorders, and blood disorders is on the rise globally. Patients with these conditions often require frequent blood transfusions as part of their treatment regimens. Antibody screening is essential for identifying potential alloantibodies in these patients, which may develop because of previous transfusions or pregnancies. Advances in laboratory techniques and technologies have made antibody screening more efficient, sensitive, and cost-effective. Newer screening assays and automated platforms allow for high-throughput screening of patient samples, reducing turnaround times and improving workflow efficiency in blood typing laboratories.

Regional Insights

North America emerged as the dominant region in the Global Blood Group Typing Market in 2023. North America boasts advanced healthcare infrastructure, including state-of-the-art laboratories, well-equipped healthcare facilities, and sophisticated blood typing technologies. This enables healthcare providers in the region to offer comprehensive blood typing services with high levels of accuracy and efficiency. The region is a hub for technological innovation and research in healthcare, including blood group typing. North American companies and research institutions continually invest in developing cutting-edge blood typing technologies, enhancing testing methodologies, and improving overall patient care outcomes. North America has stringent regulatory standards and quality control measures governing blood typing practices. Compliance with these standards ensures the safety, accuracy, and reliability of blood typing tests, contributing to the region's reputation for high-quality healthcare services. North America has a robust blood donation infrastructure supported by active participation from blood banks, healthcare organizations, and community-based initiatives. The availability of a steady supply of blood products facilitates timely blood typing and transfusion services, meeting the needs of patients across diverse healthcare settings.

Key Market Players

Thermo Fisher Scientific Inc.

Danaher Corporation

Illumina, inc.

Immucor, inc.

CareDx Inc.

Mesa Laboratories, Inc.

Bio-Rad Laboratories, Inc.

Merck KgaA

AliveDx Suisse SA

QuidelOrtho Corporation

Report Scope:

In this report, the Global Blood Group Typing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Blood Group Typing Market, By Product:

    Consumables Instruments Services

Blood Group Typing Market, By Technique:

    PCR-Based and Microarray Techniques Assay-Based Techniques Massively Parallel Sequencing Others

Blood Group Typing Market, By Test Type:

    Antibody Screening HLA Typing ABO Blood Tests Cross-Matching Tests Antigen Typing

Blood Group Typing Market, By End User:

    Hospitals Clinical Laboratories Blood Banks Other End Users

Blood Group Typing Market, By Region:

    North America

United States

Canada

Mexico

    Europe

Germany

United Kingdom

France

Italy

Spain

    Asia-Pacific

China

Japan

India

Australia

South Korea

    South America

Brazil

Argentina

Colombia

    Middle East & Africa

South Africa

Saudi Arabia

UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Blood Group Typing Market.

Available Customizations:

Global Blood Group Typing market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Blood Group Typing Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Consumables, Instruments, Services)
    • 5.2.2. By Technique (PCR-Based and Microarray Techniques, Assay-Based Techniques, Massively Parallel Sequencing, Others)
    • 5.2.3. By Test Type (Antibody Screening, HLA Typing, ABO Blood Tests, Cross-Matching Tests, Antigen Typing)
    • 5.2.4. By End User (Hospitals, Clinical Laboratories, Blood Banks, Other End Users)
    • 5.2.5. By Region
    • 5.2.6. By Company (2023)
  • 5.3. Market Map

6. North America Blood Group Typing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Technique
    • 6.2.3. By Test Type
    • 6.2.4. By End User
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Blood Group Typing Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Technique
        • 6.3.1.2.3. By Test Type
        • 6.3.1.2.4. By End User
    • 6.3.2. Canada Blood Group Typing Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Technique
        • 6.3.2.2.3. By Test Type
        • 6.3.2.2.4. By End User
    • 6.3.3. Mexico Blood Group Typing Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Technique
        • 6.3.3.2.3. By Test Type
        • 6.3.3.2.4. By End User

7. Europe Blood Group Typing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Technique
    • 7.2.3. By Test Type
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Blood Group Typing Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Technique
        • 7.3.1.2.3. By Test Type
        • 7.3.1.2.4. By End User
    • 7.3.2. United Kingdom Blood Group Typing Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Technique
        • 7.3.2.2.3. By Test Type
        • 7.3.2.2.4. By End User
    • 7.3.3. Italy Blood Group Typing Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Technique
        • 7.3.3.2.3. By Test Type
        • 7.3.3.2.4. By End User
    • 7.3.4. France Blood Group Typing Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Technique
        • 7.3.4.2.3. By Test Type
        • 7.3.4.2.4. By End User
    • 7.3.5. Spain Blood Group Typing Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Technique
        • 7.3.5.2.3. By Test Type
        • 7.3.5.2.4. By End User

8. Asia-Pacific Blood Group Typing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Technique
    • 8.2.3. By Test Type
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Blood Group Typing Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Technique
        • 8.3.1.2.3. By Test Type
        • 8.3.1.2.4. By End User
    • 8.3.2. India Blood Group Typing Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Technique
        • 8.3.2.2.3. By Test Type
        • 8.3.2.2.4. By End User
    • 8.3.3. Japan Blood Group Typing Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Technique
        • 8.3.3.2.3. By Test Type
        • 8.3.3.2.4. By End User
    • 8.3.4. South Korea Blood Group Typing Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Technique
        • 8.3.4.2.3. By Test Type
        • 8.3.4.2.4. By End User
    • 8.3.5. Australia Blood Group Typing Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Technique
        • 8.3.5.2.3. By Test Type
        • 8.3.5.2.4. By End User

9. South America Blood Group Typing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Technique
    • 9.2.3. By Test Type
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Blood Group Typing Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Technique
        • 9.3.1.2.3. By Test Type
        • 9.3.1.2.4. By End User
    • 9.3.2. Argentina Blood Group Typing Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Technique
        • 9.3.2.2.3. By Test Type
        • 9.3.2.2.4. By End User
    • 9.3.3. Colombia Blood Group Typing Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Technique
        • 9.3.3.2.3. By Test Type
        • 9.3.3.2.4. By End User

10. Middle East and Africa Blood Group Typing Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Technique
    • 10.2.3. By Test Type
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Blood Group Typing Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Technique
        • 10.3.1.2.3. By Test Type
        • 10.3.1.2.4. By End User
    • 10.3.2. Saudi Arabia Blood Group Typing Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Technique
        • 10.3.2.2.3. By Test Type
        • 10.3.2.2.4. By End User
    • 10.3.3. UAE Blood Group Typing Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Technique
        • 10.3.3.2.3. By Test Type
        • 10.3.3.2.4. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Product

14. Competitive Landscape

  • 14.1. Thermo Fisher Scientific Inc.
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Products & Services
    • 14.1.4. Financials (As Reported)
    • 14.1.5. Recent Developments
    • 14.1.6. Key Personnel Details
    • 14.1.7. SWOT Analysis
  • 14.2. Danaher Corporation
  • 14.3. Illumina, inc.
  • 14.4. Immucor, inc.
  • 14.5. CareDx Inc.
  • 14.6. Mesa Laboratories, Inc.
  • 14.7. Bio-Rad Laboratories, Inc.
  • 14.8. Merck KgaA
  • 14.9. AliveDx Suisse SA
  • 14.10.QuidelOrtho Corporation

15. Strategic Recommendations

16. About Us & Disclaimer